Cardiovascular disease is responsible for 30% of all deaths globally. Acute coronary syndromes, which include heart attack and unstable angina, are responsible for almost half of all deaths worldwide related to cardiovascular disease. Diabetes is a growing disease and an enormous global burden that is currently projected to affect more than 592 million people by the year 2035. Chronic kidney disease is a complex, debilitating condition that affects more than 70 million people worldwide
ALMEC has a patient-centric approach to disease treatment, so we are tackling multiple risk factors by uniting our cardiovascular (CV), metabolic and chronic kidney disease (CKD) disease areas into one integrated approach – cardiovascular and metabolic disease (CVMD).
This approach means we look at the CVMD patient as a whole, rather than by disease area, because we know that cardiovascular disease (CVD) is a well-known consequence of diabetes and CKD. Each of our focus areas seek to further reduce cardiovascular morbidity and mortality, and organ damage by addressing multiple CV risk factors.
ALMEC aims to break through conventional thinking by following what the science is telling us, we will: